|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current assets | |||||||||
| Cash | |||||||||
| Receivable from employee | |||||||||
| Prepaid expenses | |||||||||
| Reimbursement receivable | |||||||||
| Total current assets | |||||||||
| Deferred offering costs | |||||||||
| Long-term prepaid insurance | |||||||||
| Investments held in Trust Account | |||||||||
| Total Assets | |||||||||
| Liabilities and Shareholders' Deficit: | |||||||||
| Current liabilities | |||||||||
| Accrued expenses | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Accrued offering costs | |||||||||
| Promissory note - related party | |||||||||
| Advance from related party | |||||||||
| Over-allotment option liability | |||||||||
| Total current liabilities | |||||||||
| Promissory note - related party | |||||||||
| Total Liabilities | |||||||||
| Class A ordinary shares subject to possible redemption, 23,000,000 shares at redemption value of $10.77 and $10.49 per share as of September 30, 2026 and December 31, 2025, respectively | |||||||||
| Shareholders' Deficit | |||||||||
| Ordinary shares | |||||||||
| Class A ordinary shares | |||||||||
| Class B ordinary shares | |||||||||
| Share subscription receivable | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated Deficit | |||||||||
| Total Shareholders' Deficit | |||||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit |
Loading...